References

Adachi Y, Suzuki H and Sugiyama Y (2001) Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-gp. Pharmaceutical Research 18:1660-1668. Anderle P, Huang Y and Sadee W (2004) Intestinal membrane transport of drugs and nutrients: genomic membrane transporters using expression microarray. European Journal of Pharmaceutical Sciences 21:17-24.

Ano R, Kimura Y, Shima M, Matsuno R, Ueno T and Akamatsu M (2004) Relationship between structure and high-throughput screening permeability of papetide derivatives and related compounds with artificial membranes: application to prediction of Caco-2 cell permeability. Bioorganic & Medicinal Chemistry 12:257-264.

Arturrson P (1991) Cell cultures as models for drug absorption across the intestinal mucosa. Critical Reviews in Therapeutic Drug Carrier Systems 8:305-330.

Artursson P and Borchardt R (1997) Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharmaceutical Research 14:1655-1658.

Artursson P and Karlsson J (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelia (Caco-2) cells. Biochemical and Biophysical Research Communications 175:880-890.

Artursson P, Palm K and Luthman K (1996) Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery Reviews 22:67-84.

Aungst B, Nguyen N, Bulgarelli J and Oates-Lenz K (2000) The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds. Pharmaceutical Research 17:1175-1180.

Avdeef A (2001) Physicochemical profiling (solubility, permeability and charge state). Current Topics in Medicinal Chemistry 1:277-351.

Balimane PV and Chong S (2005a) Cell culture-based models for intestinal permeability: a critique. Drug Discovery Today 10:335-343.

Balimane PV and Chong S (2005b) A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay. International Journal of Pharmaceutics 301:80-88.

Balimane PV, Chong S and Morrison RA (2000) Current methodologies used for evaluation of intestinal permeability and absorption. Journal of Pharmacological and Toxicological Methods 44:301-312.

Balimane PV, Han YH and Chong S (2006) Current industrial practices of assessing permeability and P-glycoprotein interaction. AAPSJ 8:E1-13.

Behrens I, Kamm W, Dantzig A and Kissel T (2004) Variation of peptide transporter (PepT1 and HPT1) expression in Caco-2 cells as a function of cell origin. Journal of Pharmaceutical Sciences 93:1743-1754.

Beigi F, Yang Q and Lundahl P (1995) Immobilized-liposome chromatographic analysis of drug partitioning into lipid bilayers. Journal of Chromatography A. 704:215-321.

Braun A, Hammerle S, Suda K, Rothen-Rutishauser B, Gunthert M and Wunderli-Allenspach H (2000) Cell cultures as tools in biopharmacy. European Journal of Pharmaceutical Sciences 11:S51-S60.

Carr K and Toner P (1984) Morphology of the Intestinal Mucosa, in Pharmacology of the Intestine (Csaky T ed) pp 1-50, Springer, Berlin Heidelberg New York.

Chen Z, Kawabe T, Ono M, Aoki S, Sumizawa T, Furukawa T, Uchiumi T, Wada M, Kuwano M and Akiyama S (1999) Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter. Molecular Pharmacology 56:1219-1228.

Cho M, Thomson D, Cramer C, Vidmar T and Scieszka J (1989) The MDCK epithelial cell monolayer as a model cellular transport barrier. Pharmaceutical Research 6:71-77.

Chong S, Dando S, Soucek K and Morrison R (1996) In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system. Pharmaceutical Research 13:120-123.

Clark D (1999) Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. Journal of Pharmaceutical Sciences 88:807-814.

Dantzig A, Shepard R, Law K, Tabas L, Pratt S, Gillespie J, Binkley S, Kuhfeld M, Starling J and Wrighton S (1999) Selectivity of the multidrug resistance modulator, LY335979, for P-gp and effect on CYP-450 activities. Journal of Pharmacology and Experimental Therapeutics 290:854-562.

Daugherty A and Mrsny R (1999) Regulation of the intestinal epithelial paracellular barrier. Pharmaceutical Sciences and Technology Today 2:281-287.

Di L, Kerns EH, Fan K, McConnell OJ and Carter GT (2003) High throughput artificial membrane permeability assay for blood-brain barrier. European Journal of Medicinal Chemistry 38:223-232.

Dimitrijevic D, Shaw A and Florence A (2000) Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells. Journal of Pharmacy and Pharmacology 52:157-162.

Doluisio J, Billups N, DittertL, SugitaE and Swintosky J (1969) Journal of Pharmaceutical Sciences 58:1196-1200.

Dressman J (1986) Comparison of canine and human gastrointestinal physiology. Pharmaceutical Research 3:123-131.

Dressman J, Amidon G and Fleisher D (1985) Absorption potential: estimating the fraction absorbed for orally administered compounds. Journal of Pharmaceutical Sciences 74:588-589.

Dressman J, Berardi R, Dermentzoglou L, Russell T, Schmaltz S, Barnett J and Jarvenpaa K (1990) Upper gastrointestinal (GI) pH in young, healthy men and women. Pharmaceutical Research 7:756-761.

FDA (2004) Challenges and opportunity on the critical path to new medical products. FDA Report.

Grass G and Sweetana S (1989) A correlation for permeabilities of passively transported compounds in monkey and rabbit jejunum. Pharmaceutical Research 6:857-862.

Gres M, Julian B, Bourrie M, Meunier V, Roques C, Berger M, Boule, Berger Y and Fabre G (1998) Correlation between oral drug absorption in humans, apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharmaceutical Research 15:726-733.

Hidalgo I (2001) Assessing the absorption of new pharmaceuticals. Current Topics in Medicinal Chemistry 1:385-401.

Hillgren K, Kato A and Borchardt R (1995) In vitro systems for studying intestinal drug absorption. Medical Research Reviews 15:83-109.

Ho N, Park J, Morozowich W and Higuchi W (1977) Physical model approach to the design of drugs with improved intestinal absorption, in Design of biopharmaceutical properties through prodrugs and analogues. (Roche E ed) pp 136-277, APhA/APS, Washington, DC.

Horie K, Tang F and Borchardt R (2003) Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance efflux transporter. Pharmaceutical Research 20:161-168.

Houston J, Upshall D and Bridges J (1974) A Reevaluation of the importance of partition coefficients in the gastrointestinal absorption of nutrients. The Journal of Pharmacology and Experimental Therapeutics 189:244-254.

Irvine J, Takahashi L, Lockhart K, Cheong J, Tolan J, Selick H and Grove J (1999) MDCK cells: a tool for membrane permeability screening. Journal of Pharmaceutical Sciences 88:28-33.

Kansy M, Senner F and Gubernator K (1998) Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. Journal of Medicinal Chemistry 41:1007-1010.

Kararli T (1995) Comparison of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals. Biopharmaceutics & Drug Disposition 16:351-380.

Kerns E, Di L, Petusky S, Farris M, Ley R and Jupp P (2004) Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. Journal of Pharmaceutical Sciences 93:1440-1453.

Kim R, Wendel C, Leake B, Cvetkovic M, Fromm M, Dempsey P, Roden M, Belas F, Chaudhary A, Roden D, Wood A and Wilkinson G (1999) Interrelationship between substrates and inhibitors of human CYP3A and P-gp. Pharmaceutical Research 16:408-414.

Kola I and Landis J (2004) Can pharmaceutical industry reduce attrition rates? Nature Reviews: Drug Discovery 3:711-715.

Komiya I, Park J, Yamani A, Ho N and Higuchi W (1980) International Journal of Pharmaceutics 4:249-262.

Krause E, Dathe M, Wieprecht T and Bienert M (1999) Noncovalent immobilized artificial membrane chromatography, an improved method for describing peptide-lipid bilayer interactions. Journal of Chromatography 849:125-133.

Krishna R and Mayer LD (2000). Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. European Journal of Pharmaceutical Sciences 11(4):265-83.

Krishna G, Chen K, Lin C and Nomeir A (2001) Permeability of lipophilic compounds in drug discovery using in vitro human absorption model, Caco-2. International Journal of Pharmaceutics 222:77-89.

Lee K, Brower K and Thakker D (2002) Secretory transport of ranitidine and famotidine across Caco-2 cell monolayers. Journal ofPharmacological and Toxicological Methods 303:574-580.

Lennernas H (1998) Human intestinal permeability. Journal of Pharmaceutical Sciences 87:403-410.

Lennernas H, Nylander S and Ungell A (1997) Jejunal permeability: a comparison between the Ussing chamber technique and the single pass perfusion in humans. Pharmaceutical Research 14:667-671.

Lin JH (1995) Species similarities and differences in pharmacokinetics. Drug Metabolism and Disposition: the Biological Fate of Chemicals 23:1008-1021.

Lin J (2003) Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Advanced Drug Delivery Reviews 55:53-81.

Lin J and Yamazaki M (2003) Role of P-glycoprotein in pharmacokinetics. Clinical Pharmacokinetics 42:59-98.

Lipinski T, Lombardo F, Dominy B and Feeney P (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 23:3-25.

Maliepaard M, van Gastelen M, Tohgo A, Hauseer F, van Waardengurg R, de Jong L, Pluim D, Beijnen J and Schellens J (2001) Circumvention of BCRP-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918. Clinical Caner Research 7:935-941.

Murer H and Kinne R (1980) The use of isolated vesicles to study epithelial transport processes. The Journal of Membrane Biology 55:81-95.

Palm K, Luthman K, Ungell AL, Strandlund G, Beigi F, Lundahl P and Artursson P (1998) Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. Journal of Medical Chemistry 41:5382-5392.

Perloff M, Stromer E, von Moltke L and Greenblatt D (2003) Rapid assessment of P-gp inhibition and induction in vitro. Pharmaceutical Research 20:1177-1183.

Pidgeon C (1990a) Immobilized artificial membranes, in US patent p 498.

Pidgeon C (1990b) Solid phase membrane mimetics: immobilized artificial membranes. Enzyme and Microbial Technology 12:149-150.

Polli J, Jerrett J, Studenberg J, Humphreys J, Dennis S, Brower K and Wooley J (1999) Role of P-gp on CNS disposition of amprenavir, an HIV protease inhibitor. Pharmaceutical Research 16:1206-1212.

Polli J, Wring S, Humphreys J, Huang L, Morgan J, Webster L and Serabjit-Singh C (2001) Rational use of in vitro P-gp assays in drug discovery. The Journal ofPharmacology and Experimental Therapeutics 299:620-628.

Quastel J (1961) Methods of study of Intestinal absorption and Metabolism, in Methods in Medical Research (Quastel J ed) pp 255-259, Year Book Medical Publishers, Chicago.

Rege B, Yu L, Hussain A and Polli J (2001) Effect of common excipients on caco-2 transport of low-permeability drugs. Journal of Pharmaceutical Sciences 90:1776-1786.

Rege B, Kao J and Polli J (2002) Effect of non-ionic surfactants on membrane transport in Caco-2 cell monolayers. European Journal of Pharmaceutical Sciences 16:237-246.

Rubas W, Jezyk N and Grass GM (1993) Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharmaceutical Research 10:113-118.

Rubas W, Cromwell M, Shahrokh Z, Villagran J, Nguyen T, Welton M, Nguyen T and Mrsny R (1996) Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue. Journal of Pharmaceutical Sciences 85:165-169.

Ruell JA, Tsinman KL and Avdeef A (2003) PAMPA - a drug absorption in vitro model. 5. Unstirred water layer in iso-pH mapping assays and p K a(flux) - optimized design (pOD-PAMPA). European Journal of Pharmaceutical Sciences 20:393-402.

Russell T, Berardi R, Barnett J, Dermentzoglou L, Jarvenpaa K, Schmaltz S and Dressman J (1993) Upper gastrointestinal pH in 79 healthy, elderly, north American men and women. Pharmaceutical Research 10:187-196.

Saha P and Kou J (2002) Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers. European Journal of Pharmaceutics and Biopharmaceutics 54:319-324.

Schanker L, Tocco D, Brodie B and Hogben C (1958) Absorption of drugs from the rat small intestine. The Journal of Pharmacology and Experimental Therapeutics. 123:81-88.

Schurgers N and DeBlaey C (1984) International Journal ofPharmaceutics 19:283-295.

Simpson K and Jarvis B (2000) Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs 59:301-321.

Sinko PJ, Hu P, Waclawski AP and Patel NR (1995) Oral absorption of anti-AIDS nucleoside analogues. 1. Intestinal transport of didanosine in rat and rabbit preparations. Journal of Pharmaceutical Sciences 84:959-965.

Stenberg P, Luthman K, Ellens H, Lee CP, Smith PL, Lago A, Elliott JD and Artursson P (1999) Prediction of the intestinal absorption of endothelin receptor antagonists using three theoretical methods of increasing complexity. Pharmaceutical Research 16:15201526.

Stewart BH and Chan OH (1998) Use of immobilized artificial membrane chromatography for drug transport applications. Journal of Pharmaceutical Sciences 87:1471-1478.

Sun D, Lennernas H, Welage L, Barnett J, Landowski C, Foster D, Fleisher D, Lee K and Amidon G (2002) Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequence tags and correlation with permeability of 26 drugs. Pharmaceutical Research 19:1400-1416.

Tavelin S, Taipalensuu J, Hallbook F, Vellonen K, Moore V and Artursson P (2003) An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routes. Pharmaceutical Research 20:373-381.

Uhing M and Kimura R (1995) The effect of surgical bowel manipulation and anesthesia on intestinal glucose absorption in rats. The Journal of Clinical Investigation 95:2790-2798.

Ungell A-L (2004) Caco-2 replace or refine? Drug Discovery Today 1:423-430.

Ungell A, Nylander S, Bergstrand S, Sjoberg A and Lennernas H (1998) Membrane transport of drugs in different regions of the intestinal tract of the rat. Journal ofPharmaceu-tical Sciences 87:360-366.

Ussing H and Zerahn K (1951) Active transport of sodium as a source of electric current in the short-circuited isolated frog skin. Acta Physiologica Scandinavica 23:110-127.

Van Rees H, De Wolff F and Noach E (1974) European Journal of Pharmacology 28:310-315.

Volk E and Schneider E (2003) Wild type BCRP is a methotrexate ployglutamate transporter. Cancer Research 63:5538-5543.

Walter E and Kissel T (1995) Heterogeneity in the human intestinal cell line Caco-2 leads to differences in transepithelial transport. European Journal ofPharmaceutical Sciences 3:215-230.

Watanabe T, Miyauchi S, Sawada Y, Iga T, Hanano M, Inaba M and Sugiyama Y (1992) Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver: possible roles of P-gp in biliary excretion of vincristine. Journal of Hepatology 16:77-88.

Wessel M, Jurs P, Tolan J and Muskal S (1998) Prediction of human intestinal absorption of drug compounds. Journal of Chemical Information and Computer Sciences 38:726-735.

Wilson T and Wiseman G (1954) The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface. The Journal of Physiology 123:116-125.

Woehlecke H, Pohl A, Alder-Berens N, Lage H and Herrmann A (2003) Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2). Biochemical Journal 376:489-495.

Yamazaki M, Neway W, Ohe T, Chen I, Rowe J, Hochman J, Chiba M and Lin J (2001) In vitro substrate identification studies for P-gp mediated transport: Species difference and predictability of in vivo results. The Journal of Pharmacology and Experimental Therapeutics 296:723-735.

Yang C, Cai S, Liu H and Pidgeon C (1996) Immobilized artificial membranes - screens for drug membrane interactions. Advanced Drug Delivery Reviews 23:229-256.

Zhang S, Yang X and Morris M (2004) Flavonoids are inhibitors of BCRP-mediated transport. Molecular Pharmacology 65:1208-1216.

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment